January 26, 2025
Pleio’s Chief Pharmacy Officer Mark Gregory, RPh discusses how oral GLP-1 medication will impact the patient medication journey, highlighting how easier access may improve initiation but not necessarily adherence. He explores how fragmented support, knowledge gaps, and emotional barriers can undermine persistence, and why sustained outcomes will depend on coordinated guidance beyond the prescription.
December 23, 2025
Pleio CEO Michael Oleksiw examines why, despite decades of digital innovation and billions invested, medication adherence remains stuck at 50%. Drawing on analysis of more than 140,000 patient conversations, he explores how the “Underminers” shape patient behavior and why the future of pharma depends on combining AI-driven insight with human connection to create lasting adherence.
December 3, 2025
Pleio’s AI platform, OLLIE, analyzed over 140,000 patient interactions to identify the top drivers of non-adherence across seven dimensions, including emotion, knowledge, and skills.
November 13, 2025
On “The Tech Glow Up” live from HLTH 2025, Vital.io and Pleio share how AI can make healthcare more human—from translating medical jargon to uncovering emotional barriers that hinder adherence and patient trust.
October 30, 2025
Jen Butler, CCO at Pleio, highlights new research linking loneliness to poor adherence and explains why pharma must pair digital tools with empathetic, human-centered patient support to improve outcomes.
October 30, 2025
Pleio CCO Jen Butler contributes a guest column to the October/November edition of Drug Store News. Therapies and technologies have advanced, but the lived experience of patients has often grown more isolating. Butler reimagines support for specialty patients through empathy and human connection.
FOR MEDIA INQUIRIES PLEASE EMAIL media@pleio.com.